Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
Joseph D. Khoury, Éric Solary, Oussama Abla, et al.
Leukemia (2022) Vol. 36, Iss. 7, pp. 1703-1719
Open Access | Times Cited: 2535

Showing 1-25 of 2535 citing articles:

Acute myeloid leukemia: 2023 update on diagnosis, risk‐stratification, and management
Shai Shimony, Maximilian Stahl, Richard M. Stone
American Journal of Hematology (2023) Vol. 98, Iss. 3, pp. 502-526
Open Access | Times Cited: 232
Acute myeloid leukaemia
Courtney D. DiNardo, Harry P. Erba, Sylvie D. Freeman, et al.
The Lancet (2023) Vol. 401, Iss. 10393, pp. 2073-2086
Open Access | Times Cited: 182
Primary myelofibrosis: 2023 update on diagnosis, risk‐stratification, and management
Ayalew Tefferi
American Journal of Hematology (2023) Vol. 98, Iss. 5, pp. 801-821
Open Access | Times Cited: 167
Prediction of Risk for Myeloid Malignancy in Clonal Hematopoiesis
Lachelle D. Weeks, Abhishek Niroula, Donna Neuberg, et al.
NEJM Evidence (2023) Vol. 2, Iss. 5
Open Access | Times Cited: 160
Diagnosis and Treatment of Myelodysplastic Syndromes
Mikkael A. Sekeres, Justin Taylor
JAMA (2022) Vol. 328, Iss. 9, pp. 872-872
Closed Access | Times Cited: 131
Recent advances in targeted therapies in acute myeloid leukemia
Rahul S. Bhansali, Keith W. Pratz, Catherine Lai
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 123
Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial
Uwe Platzbecker, Matteo Giovanni Della Porta, Valeria Santini, et al.
The Lancet (2023) Vol. 402, Iss. 10399, pp. 373-385
Closed Access | Times Cited: 103
Myelodysplastic syndromes: 2023 update on diagnosis, risk‐stratification, and management
Guillermo Garcia‐Manero
American Journal of Hematology (2023) Vol. 98, Iss. 8, pp. 1307-1325
Open Access | Times Cited: 91
The WHO Classification of Haematolymphoid Tumours
Ian A. Cree
Leukemia (2022) Vol. 36, Iss. 7, pp. 1701-1702
Open Access | Times Cited: 90
Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes
Peter Valent, Amy D. Klion, Florence Roufosse, et al.
Allergy (2022) Vol. 78, Iss. 1, pp. 47-59
Open Access | Times Cited: 90
A practical approach to curate clonal hematopoiesis of indeterminate potential in human genetic datasets
Caitlyn Vlasschaert, Taralynn Mack, J. Brett Heimlich, et al.
Blood (2023)
Open Access | Times Cited: 86
Myeloproliferative Neoplasms, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
Aaron T. Gerds, Jason Gotlib, Haris Ali, et al.
Journal of the National Comprehensive Cancer Network (2022) Vol. 20, Iss. 9, pp. 1033-1062
Open Access | Times Cited: 82
Genetic basis and molecular profiling in myeloproliferative neoplasms
Damien Luque Paz, Róbert Královics, Radek C. Skoda
Blood (2022) Vol. 141, Iss. 16, pp. 1909-1921
Open Access | Times Cited: 81
Burkitt lymphoma
Cristina López, Birgit Burkhardt, John K. C. Chan, et al.
Nature Reviews Disease Primers (2022) Vol. 8, Iss. 1
Closed Access | Times Cited: 79
Polycythemia vera: 2024 update on diagnosis, risk‐stratification, and management
Ayalew Tefferi, Tiziano Barbui
American Journal of Hematology (2023) Vol. 98, Iss. 9, pp. 1465-1487
Open Access | Times Cited: 79
Myelofibrosis
Francesco Passamonti, Barbara Mora
Blood (2022) Vol. 141, Iss. 16, pp. 1954-1970
Open Access | Times Cited: 70
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes
Elisabetta Sauta, Marie Robin, Matteo Bersanelli, et al.
Journal of Clinical Oncology (2023) Vol. 41, Iss. 15, pp. 2827-2842
Open Access | Times Cited: 65
Clonal haematopoiesis and dysregulation of the immune system
Roger Belizaire, Waihay J. Wong, Michelle L. Robinette, et al.
Nature reviews. Immunology (2023) Vol. 23, Iss. 9, pp. 595-610
Closed Access | Times Cited: 65
The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades
Elias Jabbour, Nicholas J. Short, Nitin Jain, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 64
Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease
Esra D. Gümüşer, Art Schuermans, So Mi Jemma Cho, et al.
Journal of the American College of Cardiology (2023) Vol. 81, Iss. 20, pp. 1996-2009
Open Access | Times Cited: 64
Systemic mastocytosis in adults: 2023 update on diagnosis, risk stratification and management
Animesh Pardanani
American Journal of Hematology (2023) Vol. 98, Iss. 7, pp. 1097-1116
Open Access | Times Cited: 60
Multiparameter prediction of myeloid neoplasia risk
Muxin Gu, Sruthi Cheloor Kovilakam, William G. Dunn, et al.
Nature Genetics (2023) Vol. 55, Iss. 9, pp. 1523-1530
Open Access | Times Cited: 54
Validation and refinement of the 2022 European LeukemiaNet genetic risk stratification of acute myeloid leukemia
Christian Rausch, Maja Rothenberg‐Thurley, Annika Dufour, et al.
Leukemia (2023) Vol. 37, Iss. 6, pp. 1234-1244
Open Access | Times Cited: 46
Causes and consequences of clonal hematopoiesis
Lachelle D. Weeks, Benjamin L. Ebert
Blood (2023) Vol. 142, Iss. 26, pp. 2235-2246
Open Access | Times Cited: 46
AML classification in the year 2023: How to avoid a Babylonian confusion of languages
Sandra Huber, Constance Baer, Stephan Hütter, et al.
Leukemia (2023) Vol. 37, Iss. 7, pp. 1413-1420
Open Access | Times Cited: 43
Page 1 - Next Page

Scroll to top